16 June 202116 June 2021 Wall Street wins signal the start of a synthetic biology revolution Last month, Ginkgo Bioworks landed a blank-check deal that valued the company at $15 billion, more than triple what it was worth last year
9 June 202116 June 2021 Ginkgo Bioworks going public for $15bn SPAC deal Company will be a publicly-traded company on the New York Stock Exchange and will continue to make other filings with the SEC in line with public company requirements